About Xlumena
Xlumena is a company based in Mountain View (United States) founded in 2008 was acquired by Boston Scientific in April 2015. Xlumena has raised $73.68 million across 7 funding rounds from investors including Boston Scientific, Western Technology Investment and Ascent Biomedical Ventures. The company has 2 employees as of December 31, 2017. Xlumena operates in a competitive market with competitors including Sequana Medical, Yaqrit, Salient Surgical Technologies, CalmiGo and Autem Therapeutics, among others.
- Headquarter Mountain View, United States
- Employees 2 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Xlumena
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$73.68 M (USD)
in 7 rounds
-
Latest Funding Round
$25 M (USD), Series C
Dec 03, 2014
-
Investors
Boston Scientific
& 7 more
-
Employee Count
2
as on Dec 31, 2017
-
Acquired by
Boston Scientific
(Apr 01, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Xlumena
Xlumena has successfully raised a total of $73.68M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $25 million completed in December 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Xlumena
Xlumena has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Western Technology Investment and Ascent Biomedical Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
A healthcare-focused investment firm supporting innovative company growth.
|
Locked | Locked | Locked | |
|
VC firm investing in the US
|
Locked | Locked | Locked |
Investor details for Xlumena
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xlumena
Investment portfolio details for Xlumena
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xlumena
Detailed financials for Xlumena
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xlumena Comparisons
Peer comparison for Xlumena
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xlumena
Xlumena operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, Yaqrit, Salient Surgical Technologies, CalmiGo and Autem Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| Locked | Locked | Locked |
Liver dialysis devices for treating cirrhosis and failure are developed.
|
|
| Locked | Locked | Locked |
Electrosurgical systems for surgical resections and procedures are developed.
|
|
| Locked | Locked | Locked |
Stress-relief devices are developed using smart breathing regulation technology.
|
|
| Locked | Locked | Locked |
Bioelectric platforms for cancer treatment are developed.
|
Detailed competitors of Xlumena
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xlumena
Complete news archive for Xlumena
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xlumena
Xlumena was founded in 2008.
Xlumena is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Xlumena is a funded company, having raised a total of $73.68M across 7 funding rounds to date.
As of Dec 31, 2017, the latest employee count at Xlumena is 2.
Xlumena develops image-guided therapeutic endoscopy products. It develops Bile Duct Stenting, a self-expanding anchor stent and precision XL delivery system; Translumenal Access for Translumenal delivery of endoscopic instruments and devices using the integrated Exchange Free (XF) delivery system; Gallbladder Drainage that drains the gallbladder into the duodenum or stomach using a lumenal approximating stent and precision delivery system; and Bile and Pancreatic Duct Drainage, which creates an anastomotic bypass to drain the bile ducts or pancreatic ducts into the duodenum using the integrated XF delivery system, lumenal approximation tools, and novel anchor stent. The company also develops Pseudocyst Drainage, an integrated XF system designed to enable reliable pseudocyst drainage; and Hiatal Hernia Repair that enables the repair of a hiatal hernia from inside the GI lumen.
Xlumena's top competitors include Sequana Medical, Yaqrit and CalmiGo.
Xlumena has 8 investors. Key investors include Boston Scientific, Western Technology Investment, Ascent Biomedical Ventures, Aperture Venture Partners, and Prism Venture Partners.